3 not yet recruiting, 2 recruiting, 1 active not recruiting, 1 completed. 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Not yet recruiting 1 |
Follow Alcohol-associated Liver Disease: new trials by email Literature Review of Alcohol-associated Liver Disease trials Research Report on Alcohol-associated Liver Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pomegranate Dietary Supplements in AUD and ALD Pomegranate Dietary Ssupplement - Alcohol Use Disorder, Alcohol-associated Liver Disease | Not yet recruiting | University of Louisville | 144 | 2027-01-01 | 2026-07-24 | |
| An AI-powered Virtual Reality Brief Intervention for Hospitalized Patients With Alcohol-Associated Liver Disease (SOBER-VR) SOBER-VR - Alcohol-associated Liver Disease | Phase 1 | Not yet recruiting | The Cleveland Clinic | 30 | 2026-11-01 | 2026-10-15 |
| Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease PEth Based Contingency Management, PEth Monitoring with Fixed Incentives - Alcohol Use Disorder, Alcohol-associated Liver Disease | Not applicable | Not yet recruiting | Massachusetts General Hospital | 90 | 2026-08-01 | 2026-03-12 |
| Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD) Implementation Intervention - Alcohol Use Disorder, Alcohol-associated Liver Disease | Not applicable | Recruiting | Yale University | 30 | 2026-04-05 | 2026-05-07 |
| A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Alcohol Liver Disease An observational, non-interventional study design. - Alcohol-associated Liver Disease | Completed | Zhujiang Hospital | 40 | 2025-07-01 | 2025-12-16 | |
| RESTORE TRIAL: Study of the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD) Pemvidutide, Placebo - Alcohol-associated Liver Disease | Phase 2 | Active not recruiting | Altimmune, Inc. | 121 | 2025-06-16 | 2026-08-17 |
| LGG Supplementation in Patients With AUD and ALD : Placebo for Probiotic, Lactobacillus Rhamnosus GG - Alcohol Use Disorder, Alcohol-associated Liver Disease | Phase 2 | Recruiting | University of Louisville | 60 | 2022-06-01 | 2025-10-31 |
Alcoholism (4) · Liver Cirrhosis, Alcoholic (2) · Alcohol Abstinence (1) · Liver Diseases (1)
Alcohol-Related Disorders (4) · Chemically-Induced Disorders (4) · Mental Disorders (4) · Substance-Related Disorders (4) · Alcohol-Induced Disorders (2) · Digestive System Diseases (2) · Fibrosis (2) · Liver Cirrhosis (2) · Liver Diseases, Alcoholic (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Behavior (1) · Drinking Behavior (1) · Liver Diseases (1)
Ethanol (1) · Probiotics (1)
University of Louisville (2) · Altimmune, Inc. (1) · Massachusetts General Hospital (1) · The Cleveland Clinic (1) · Yale University (1) · Zhujiang Hospital (1)
United States (4) · China (1) · Puerto Rico (1)
Craig J McClain, MD (2) · Vatsalya Vatsalya, MD (2) · Harsh Tiwari, MD (1) · Lamia Haque (1) · Venkatakrishna R Jala, PhD (1) · Xiaolong He, xiaolong (1)
K23AA029198 (1), K23AA031334 (1), K23AA033142 (1), P50AA024337 (1), R34AA032300 (1)